QCW-43371-93594
2 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-19
- 2021-04-26
-
2021-04-28
Dose 2 — Pfizer-BioNTech
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
-
2021-07-28
Survey response — 3 month, dose 2MedDRA: Amenorrhoea — Feeling: GoodMedDRA releases: 2021-09,2024-11 · check-in answers available
- 2021-10-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech |
Free text
Release 9
Symptoms: I did not have a menstrual cycle for three months after receiving the vaccine. I had my first cycle roughly 90 days after getting the vaccine and there was no positive pregnancy test or miscarriage during that time period.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amenorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release